BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  INSYS Therapeutics Founder Dr. John N. Kapoor Steps Down from Board of Directors

  The founder was charged with bribing doctors to prescribe opioid painkillers last week.

  October 30, 2017

   · 

  2 min read
• Drug Development

  CARMAT Accelerates the Internationalization of the PIVOTAL Study and Obtains the Approval to Perform Implants in the Czech Republic

  CARMAT announces it has received the approval to perform, within the framework of the PIVOTAL study protocol approved by the ANSM (French national agency for the safety of medicines and health products),

  October 30, 2017

   · 

  3 min read
• Pluristem Proposes to Launch a Public Offering of Common Stock on the Tel Aviv Stock Exchange After Concluding an Israeli Institutional Investors Tender

  The Company has engaged Leader Underwriters (1993) Ltd. (“Leader”) as its advisor for the offering.

  October 30, 2017

   · 

  5 min read
• Okayama University Research: Link Between Biological-Clock Disturbance and Brain Dysfunction Found

  Researchers at Okayama University describe in the Journal of Neuroscience that a certain protein known to play a major role in circadian rhythmicity --humans’ intrinsic 24-hour biological cycle -- is also key to proper brain functioning.

  October 30, 2017

   · 

  4 min read
• Business

  Igenomix US and PracticeHwy.com Announce a New Collaboration

  This collaboration will allow unprecedented access and ease of ordering/receiving test results to the more than 130 IVF centers who currently use eIVF in their practice.

  October 30, 2017

   · 

  3 min read
• Crescendo Bioscience Announces Six Presentations at the American College of Rheumatology 2017 Annual Meeting

  Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. , today announced that six studies on Vectra® DA will be featured at the American College of Rheumatology (ACR) meeting being held Nov. 3-8, 2017 in San Diego,

  October 30, 2017

   · 

  4 min read
• Deals

  Concept Life Sciences Announces Acquisition of Aquila BioMedical

  The acquisition is a pivotal addition to the comprehensive range of integrated services Concept provides, supporting customers throughout the drug discovery and development process.

  October 30, 2017

   · 

  2 min read
• Business

  Astellas Appoints Gary Thal, M.D., to VP, Specialty, Medical Affairs, Americas

  Astellas today announced Gary Thal, M.D., has been promoted to VP, Specialty, Medical Affairs, Americas and will assume overall responsibility for the strategic direction of the Specialty product portfolio.

  October 30, 2017

   · 

  2 min read
• Titan Medical Receives CDN $8.4 Million From Warrants

  As of October 25, 2017, 42,622,290 common shares have been issued through the exercise of 40,911,666 warrants at CDN $0.20 per share, 5,000 warrants at CDN $0.40 per share, and 1,705,624 broker warrants at CDN $0.15 per share.

  October 30, 2017

   · 

  1 min read
• FactBio Launches Annotated Metadata Collection

  The Annotated Metadata Collection covers a wide range of areas such as functional genomics, genomic variation and toxicology.

  October 30, 2017

   · 

  2 min read